Epstein Secrets

tlev Engel Klaus Engel Richard P. Eno David R. Epstein Mary Callahan Erdoes Charles W. Ergen Paula E

kil Beshir Ulrich L. Bettermann Erik Behermann Jeffrey L. Bewkes Donald S. Beyer Homi K. Bhabha Neera

ead, International Trade and Finance Chief Executive Officer Adjunct Professor of Economics Hisham El-Khazindar Managing Director and Co-Founder Christopher J. Elias Johan Eliasch Olafur Eliasson Michael J. Elliott Lawrence Elliott Gerd Elliott Vernon J. Ellis Stephen Ellis President and Chief Executive Offi

Chief Executive Officer Metabolix USA David R. Epstein Head. Pharma Division Novartis AG Switzerland

rman of the Board OBO Bettermann Group Germany Jeffrey L. Bewkes Chairman and Chief Executive Officer

nd Adjunct Professor of Economics University of Lund Sweden Hisham El-Khazindar Managing Director and Co-Founder Citadel Capital S.A.E. Egypt Christopher J. Elias President and Chief Executive Officer PATH (Programme for USA Appropriate Technology in Health) Johan Eliasch Chairman and Chief Executive Off

Chief Executive Officer Metabolix USA David R. Epstein Head. Pharma Division Novartis AG Switzerland

rman of the Board OBO Bettermann Group Germany Jeffrey L. Bewkes Chairman and Chief Executive Officer

nd Adjunct Professor of Economics University of Lund Sweden Hisham El-Khazindar Managing Director and Co-Founder Citadel Capital S.A.E. Egypt Christopher J. Elias President and Chief Executive Officer PATH (Programme for USA Appropriate Technology in Health) Johan Eliasch Chairman and Chief Executive Off

tlev Engel Klaus Engel Richard P. Eno David R. Epstein Mary Callahan Erdoes Charles W. Ergen Paula Esco

s John Ehara Jack Ehnes Ralph Eichler Espen Barth Eide Jérg Eigendorf Maria Eitel Stuart E. Eizenstat Daniel Ek Klas Eklund Hisham El-Khazindar Christopher J. Elias Johan Eliasch Olafur Eliasson Gerri Elliott Lawrence Elliott Michael J. Elliott Stephen Ellis Sir Vernon J. Ellis David T. Ellwood Eduardo S. Els